Table 2.

Parameter estimates between control and Ca²⁺ channel blockade condition during 0.05 and 0.10 Hz OLBNP

	0.10 Hz		0.05 Hz		2 × 2 RMANOVA
	Control	Blockade	Control	Blockade	Freq	Con	Freq × Con
Windkessel model
Capacitive gain (cm mmHg−1)	1.7 ± 0.30	1.8 ± 0.58	1.6 ± 0.87	1.4 ± 0.60	0.23	0.94	0.40
Conductive gain (cm s−1 mmHg−1)	0.022 ± 0.077	1.8 ± 0.58	−0.008 ± 0.21	0.20 ± 0.35	0.60	<0.05	0.28
R2	0.99 ± 0.016	0.99 ± 0.0097	0.91 ± 0.065	0.89 ± 0.068	—	—	—
Normalised Windkessel model
Capacitive gain (% s−1 mmHg−1)	2.3 ± 0.45	2.9 ± 0.87	2.4 ± 1.2	2.3 ± 0.93	0.38	0.58	0.22
Conductive gain (% mmHg−1)	0.11 ± 0.36	0.13 ± 0.10	−0.038 ± 0.32	0.27 ± 0.51	0.96	<0.05	0.26
R2	0.97 ± 0.03	0.99 ± 0.0044	0.91 ± 0.069	0.89 ± 0.067	—	—	—
Conductance model
Conductive gain (cm s−1 mmHg−1)	0.82 ± 0.32	0.96 ± 0.35	0.21 ± 0.32	0.48 ± 0.40	<0.05	<0.05	0.17
R2	0.53 ± 0.23	0.64 ± 0.22	0.34 ± 0.31	0.42 ± 0.33	—	—	—
Normalised conductance model
Conductive gain (% mmHg−1)	1.1 ± 0.35	1.5 ± 0.49	0.31 ± 0.47	0.71 ± 0.52	<0.05	<0.05	0.91
R2	0.97 ± 0.031	0.89 ± 0.068	0.91 ± 0.069	0.99 ± 0.005	—	—	—

Freq, frequency; Con, drug condition; Freq × Con, interaction.